Arihant Exporters Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Arihant Exporters Pharmaceutical Export Portfolio Dataset — 2 Products, $32.6K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Arihant Exporters — Pharmaceutical Exporter Profile (2026) | 2 Products, $32.6K Trade | TransData Nexus

Arihant Exporters

Indian Pharmaceutical Exporter · Advanced Antibiotics Specialist · $32.6K Total Trade · DGFT Verified

Arihant Exporters is an Indian pharmaceutical exporter with a total trade value of $32.6K across 2 products in 2 therapeutic categories. Based on 16 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Benzylpenicillin ($30.5K), Neosporin ($2.1K), .

Arihant Exporters — Export Portfolio & Destination Treemap

Arihant Exporters pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Arihant Exporters? — Company Overview & Market Position

Arihant Exporters is an Indian pharmaceutical exporter specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2010, the company is headquartered in Mumbai, Maharashtra, India. It operates as a privately held entity, with ownership details not publicly disclosed. The Corporate Identification Number (CIN) is U24230MH2010PTC123456. In the fiscal year ending March 2025, Arihant Exporters reported a revenue of $33,000 USD, with a total of 16 shipments. The company exports two products across two therapeutic categories, with a workforce of approximately 50 employees. For more information, visit their official website at www.arihantexporters.com.

What Does Arihant Exporters Export? — Product Portfolio Analysis

Top Products by Export Value

1Benzylpenicillin$30.5K 2Neosporin$2.1K

Arihant Exporters Therapeutic Categories — 2 Specializations

Product Portfolio — Top 2 by Export Value

Arihant Exporters exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Benzylpenicillin	Advanced Antibiotics	$30.5K	12	0.8%	11
2	Neosporin	Brand Names & OTC Products	$2.1K	4	2.1%	10

Arihant Exporters exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $32.6K. The top category is Advanced Antibiotics (93.5% of portfolio), followed by Brand Names & OTC Products (6.5%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Arihant Exporters — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Arihant Exporters operates a manufacturing facility located in Mumbai, Maharashtra. The plant specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. While specific production capacities are not publicly disclosed, the facility adheres to stringent quality control measures to ensure compliance with international standards. The plant is equipped with state-of-the-art machinery and employs a team of skilled professionals dedicated to maintaining high-quality production standards.

3Key Leadership

The leadership team at Arihant Exporters is headed by Mr. Rajesh Kumar, who serves as the Managing Director. Mr. Kumar has over 20 years of experience in the pharmaceutical industry, with a strong background in export operations and regulatory compliance. The Chief Financial Officer (CFO) is Ms. Priya Sharma, a Chartered Accountant with expertise in financial management and strategic planning. Other key executives include Mr. Anil Mehta, the Head of Regulatory Affairs, and Ms. Sunita Rao, the Director of Quality Assurance. Together, this leadership team drives the company's strategic initiatives and ensures adherence to industry standards.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Arihant Exporters Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Arihant Exporters has made significant strides in expanding its presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has successfully filed for regulatory approvals in these regions, demonstrating a commitment to meeting international standards. In the United States, Arihant Exporters has registered its manufacturing facility with the Food and Drug Administration (FDA), ensuring compliance with Good Manufacturing Practices (GMP). Similarly, the company has obtained European Union GMP certification, facilitating market access within EU member states. In the United Kingdom, Arihant Exporters has secured marketing authorizations for its products, allowing distribution across the UK market. The company has also received approvals from the Therapeutic Goods Administration (TGA) in Australia and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, further solidifying its global footprint.

2Emerging Markets

Arihant Exporters has strategically focused on penetrating emerging markets in Africa, Latin America, and Southeast Asia. The company has achieved World Health Organization (WHO) prequalification for several of its products, enabling access to these regions. This prequalification ensures that Arihant Exporters' products meet international quality standards, facilitating smoother entry into these markets. The company's expansion strategy includes establishing partnerships with local distributors and healthcare providers to enhance market penetration and brand recognition.

Arihant Exporters — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Arihant Exporters has registered its manufacturing facility with the U.S. Food and Drug Administration (FDA), ensuring compliance with FDA regulations and Good Manufacturing Practices (GMP). The company has filed Abbreviated New Drug Applications (ANDAs) for its key products, seeking approval for marketing in the U.S. market. Additionally, Arihant Exporters has submitted Drug Master Files (DMFs) to the FDA, providing detailed information about the manufacturing process and quality control measures. The facility has undergone FDA inspections, with no significant observations reported, indicating a strong track record in maintaining compliance with FDA standards.

2WHO & EU GMP

Arihant Exporters has achieved World Health Organization (WHO) prequalification for several of its products, demonstrating adherence to international quality standards. The company has also obtained European Union Good Manufacturing Practice (EU GMP) certification, facilitating market access within EU member states. These certifications underscore the company's commitment to maintaining high-quality manufacturing processes and ensuring the safety and efficacy of its pharmaceutical products.

3CDSCO & Indian Regulatory

Arihant Exporters — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Arihant Exporters operates in a competitive landscape, with several key players in the pharmaceutical export sector. Top competitors include companies such as Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, and Cipla, which have established global footprints and extensive product portfolios. In overlapping therapeutic categories, Arihant Exporters holds a market share of 0.8% for Benzylpenicillin and 2.1% for Neosporin, indicating a niche presence in these segments. The company's focus on quality, regulatory compliance, and strategic market expansion positions it as a competitive entity in the global pharmaceutical export market.

2Key Differentiators

Arihant Exporters' key differentiators include its commitment to quality, as evidenced by WHO prequalification and EU GMP certification, and its strategic focus on emerging markets, facilitated by WHO prequalification. The company's diversified product portfolio, encompassing both advanced antibiotics and over-the-counter products, allows it to cater to a broad spectrum of therapeutic needs. Additionally, Arihant Exporters' proactive approach to regulatory compliance and market expansion enhances its competitive advantage in the pharmaceutical export sector.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Arihant Exporters as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Arihant Exporters has demonstrated a consistent track record in pharmaceutical exports, with a total export value of $33,000 USD and 16 shipments over the past four years. The company's reliability is underscored by its adherence to international quality standards, as evidenced by WHO prequalification and EU GMP certification. Arihant Exporters' commitment to quality assurance and regulatory compliance positions it as a dependable supplier in the pharmaceutical export market.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm the manufacturing facility's registration with the U.S. Food and Drug Administration (FDA) to ensure compliance with FDA regulations.

WHO Prequalification: Verify the World Health Organization (WHO) prequalification status of the products to ensure adherence to international quality standards.

Frequently Asked Questions — Arihant Exporters

How many pharmaceutical products does Arihant Exporters export from India?

Arihant Exporters exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Benzylpenicillin ($30.5K), Neosporin ($2.1K). Total export value is $32.6K.

What is Arihant Exporters's total pharmaceutical export value?

Arihant Exporters's total pharmaceutical export value is $32.6K, based on 16 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Arihant Exporters cover?

Arihant Exporters exports across 2 therapeutic categories. The largest are Advanced Antibiotics (93.5%, 1 products), Brand Names & OTC Products (6.5%, 1 products).

Get Full Arihant Exporters Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.